Key facts
- Giles AI’s last known valuation is $16.7M (Jun 2025).
- It has raised $990K; the latest was Angel (individual) ($990K) in Jun 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Giles AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Giles AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Giles AI
Developer of AI-powered assistant services designed for healthcare businesses. The company's platform supports faster, smarter, and more compliant decision-making by delivering an AI-powered tool that enhances workflows in medical research, clinical trials, regulatory affairs, public health, CRO services and healthcare academia, enabling organizations to access real-time insights and accelerate their research, all within a single, efficient ecosystem.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 16
- Website
- giles.app/
- Ownership
- Privately Held (backing)
Giles AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Giles AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Giles AI in its N-PORT filings yet. We sweep new filings monthly.